Quick Answer
Outset Medical, Inc. reported Diluted EPS of $5.37 per share (loss) for fiscal year 2025.
Outset Medical, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$5.37 | +85.5% |
| 2024 | -$36.96 | +29.3% |
| 2023 | -$52.28 | -1446.7% |
| 2022 | -$3.38 | -17.0% |
| 2021 | -$2.89 | +40.4% |
| 2020 | -$4.85 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.00 | +87.5% | +3.8% |
| June 30, 2025 | -$1.04 | +89.6% | +71.6% |
| March 31, 2025 | -$3.66 | +68.9% | +54.4% |
| September 30, 2024 | -$8.02 | -762.4% | +19.5% |
| June 30, 2024 | -$9.96 | -1006.7% | +15.4% |
| March 31, 2024 | -$11.77 | -1207.8% | -1165.6% |
| September 30, 2023 | -$0.93 | -9.4% | -3.3% |
| June 30, 2023 | -$0.90 | +2.2% | +0.0% |
- Outset Medical, Inc. showed an increase of +85.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Outset Medical, Inc.’s diluted eps has declined by 10.7% (from $4.85 per share (loss) to $5.37 per share (loss)).
- The most recent figure is from Outset Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: